Event honored scientists who received their first R01 research grants from the National Institutes of Health
WashU Medicine celebrates first R01 recipients

Event honored scientists who received their first R01 research grants from the National Institutes of Health
Nearly two dozen experimental therapies targeting the immune system are in clinical trials for Alzheimer’s disease, a reflection of the growing recognition that immune processes play a key role in driving the brain damage that leads to confusion, memory loss and other debilitating symptoms. Many of the immunity-focused Alzheimer’s drugs under development are aimed at […]